ERBB2 and cancer: TZB is a monoclonal Ab specific to human epidermal growth factor receptor 2 (Her2) that induces its therapeutic effects in Her2-positive cancer by directing Ab-dependent cell-mediated cytotoxicity.33 However, the therapeutic efficacy of such Abs is limited because of insufficient penetration into solid tumors.